The role of lipid nanoparticles and its surface modification in reaching the brain: an approach for neurodegenerative diseases treatment.

Nanomedicine is a field of science that employs materials in the nanometer scale. Specifically, the use of nanoparticles (NPs) has some medical applications due to their structure, for example, the ability to cross the biological barriers, and their effectiveness avoiding some drug delivery problems. Because of that, in the last years, the use of NPs has been raised as a workable solution for neurodegenerative diseases (ND) treatment [1,2]. NDs are characterized by a continuous structural and functional neuronal loss, usually correlated with neuronal death. Between NDs, Alzheimer disease (AD) and Parkinson's disease (PD) are the most common disorders worldwide, becoming a serious economic burden and public health problem [3].